Remove Heart Valves Remove Hospital Remove TAVR
article thumbnail

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. At Medtronic, we continue to emphasize that valve design matters. healthcare system perspective.

TAVR 52
article thumbnail

Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports

DAIC

Tang is currently serving as a professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , the surgical director of the Structural Heart Program at the Mount Sinai Health System , and the director of Structural Heart Education at the Mount Sinai Fuster Heart Hospital in New York.

TAVR 105
article thumbnail

Minimally Invasive Options For High-Risk Heart Surgery

MIBHS

It’s often preferred to high-risk heart surgery because it results in less trauma to the chest and smaller, more discreet scars. It also allows for less blood loss, reduced pain, shorter hospital stays, and a lower chance of infection. How Does Minimally Invasive Heart Surgery Work Every minimally invasive heart surgery is unique.

article thumbnail

Gilbert H. L. Tang Appointed Editor-in-Chief of JACC: Case Reports

DAIC

Tang is currently serving as a professor in the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , the surgical director of the Structural Heart Program at the Mount Sinai Health System, and the director of Structural Heart Education at the Mount Sinai Fuster Heart Hospital in New York.

TAVR 52
article thumbnail

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

DAIC

The SMART trial is the first randomized head-to-head comparison of the two most widely used TAVR devices—the supra-annular self-expanding Evolut PRO/PRO+/FX and the balloon-expandable SAPIEN 3/3 Ultra. percentage points—in one-year bioprosthetic valve dysfunction favoring the Evolut platform. of those receiving the SAPIEN valve.

TAVR 59
article thumbnail

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

DAIC

Sinai Hospital (New York, NY). Featuring numerous abstracts with fresh insights into health disparities, efficacy data for TAVR, and innovative strategies for PAD, we eagerly anticipate the convergence of professionals from diverse specialties. About 276,000 patients have undergone a TAVR procedure in the United States.

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)